Skip to main content

Table 3 Frequency, bother, and most bothersome atypical antipsychotic AEs reported by patients with schizophrenia

From: Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

  Schizophrenia, n (%)
(n = 17)
AE Categories Frequency Bother Most Bothersomea
Weight changes 16 (94)
Weight gain and/or increased appetite 16 (94) 12 (71) 7 (41)
 Weight loss and/or decreased appetite 4 (24) 0 0
Low energy 14 (82) 12 (71) 6 (35)
EPS 13 (77) 10 (59) 2 (12)
Somnolence/sedation 12 (71)
 Need to sleep/excessive sleep/excessive sleepiness 11 (65) 6 (35) 1 (6)
 ”Zombie-like”/”out of it” 4 (24) 2 (12) 1 (6)
Anxiety b 11 (65) 8 (47) 6 (35)
Mental anxiety 7 (41) 6 (35) 6 (35)
 Physical anxiety 4 (24) 4 (24) 2 (12)
 Social anxiety 1 (6) 0 1 (6)
Cognitive issues 10 (59) 6 (35) 3 (18)
Sexual function 10 (59)
 Increased sexual desire/activities 2 (12) 1 (6) 1 (6)
 Reduced sexual desire or performance 8 (47) 4 (24) 2 (12)
Increased schizophrenia positive symptoms 8 (47) 7 (41) 4 (24)
Anticholinergic-related dryness 7 (41)
 Dry eyes 1 (6) 0 0
 Dry mouth 6 (35) 5 (29) 3 (18)
 Dry skin 0 0 0
Visual problems 7 (41) 4 (24) 2 (12)
Insomnia 6 (35) 5 (29) 2 (12)
Restlessness/akathisia 6 (35) 3 (18) 3 (18)
Disequilibrium 5 (29) 3 (18) 1 (6)
Cardiovascular 5 (29)
 Hypertension 4 (24) 1 (6) 1 (6)
 Hypotension 1 (6) 1 (6) 1 (6)
QT prolongation/skipped heartbeat 0 0 0
Depressive symptoms 4 (24) 2 (12) 2 (12)
Pain 4 (24) 2 (12) 1 (6)
Bowel/digestive system changes 4 (24)
 Constipation 2 (12) 0 0
 Diarrhea 2 (12) 1 (6) 1 (6)
 Nausea/vomiting 1 (6) 1 (6) 0
Abnormal blood/laboratory test levels 4 (24)
 Anemia 1 (6) 1 (6) 1 (6)
 Hyperglycemia 1 (6) 1 (6) 0
 Hyperlipidemia 2 (12) 1 (6) 1 (6)
Irritability 3 (18) 2 (12) 1 (6)
Anger/aggression 2 (12) 2 (12) 1 (6)
Hypomania 2 (12) 2 (12) 0
Hormonal 2 (12) 1 (6) 1 (6)
Otherc 2 (12) 1 (6) 0
Major medical (diabetes) 2 (12) 1 (6) 1 (6)
Major medical (seizures) 1 (6) 1 (6) 0
Flat/restricted affect 1 (6) 0 0
Social withdrawal 1 (6) 0 0
Major medical (hypothyroidism) 0 0 0
  1. Abbreviations: EPS extrapyramidal symptoms, QT the time between the start of the Q wave and the end of the T wave in the heart’s electrical cycle
  2. a The top 5 AEs most frequently reported as most bothersome are highlighted in bold
  3. b Anxiety is reported as the sum of the participants who endorsed any of the anxiety subcodes and also accounts for participants who reported “anxiety” without noting a subcode
  4. c The category of “other” was created to represent select symptoms reported by 2 or fewer participants that were also not reported as most bothersome, most clinically important, or an AE of specific interest